Background. Functional renal impairment is a common feature of heart failure with preserved ejection fraction (HFpEF). The link between functional renal impairment and HFpEF remains incompletely understood. With hypertension and diabetes as frequent co-morbidities, patients with HFpEF are at risk of developing intra-renal vascular hemodynamic alterations that may lead to functional renal impairment and impact on prognosis. Methods. Renal resistive index (RRI) was non-invasively determined by Doppler ultrasonic examination in 90 HFpEF patients and 90 age-and sex-matched hypertensive patients without evidence of heart failure (HF) who served as controls. Clinical, laboratory and cardiac echocardiography data were obtained in HFpEF patients and controls. To investigate its possible clinical relevance, RRI was evaluated as a prognostic index of all-cause mortality and hospitalization for HF. Results. Mean RRI was substantially greater in HFpEF patients than in controls (P < 0.0001), while mean blood pressure, glomerular filtration rate, hemoglobin and serum protein levels were significantly lower in HFpEF patients than in controls. On multivariable analysis, mean RRI was independently associated with HFpEF. In addition, increased mean RRI was an independent predictor of poor outcome [hazard ratio ¼ 1.06 95% confidence interval (1.01-1.10), P ¼ 0.007] and remained significantly associated with the outcome after adjustment for univariate predictors that included low mean blood pressure, low hemoglobin concentration and low glomerular filtration rate. Conclusion. Patients with HFpEF exhibit intra-renal vascular hemodynamic alterations. The severity of intra-renal vascular hemodynamic alterations correlates with a poor outcome.
Introduction
Whether the development and progression of heart failure (HF) can be entirely ascribed to left ventricular (LV) diastolic alterations remain dubious in patients with preserved LV ejection fraction (HFpEF) [1] [2] [3] [4] . Patients with HFpEF, who frequently have hypertension and type II diabetes as comorbid conditions, commonly exhibit renal functional impairment as evidenced by elevated serum creatinine level or reduced estimated glomerular filtration rate (eGFR) [5] [6] [7] . The mechanisms that underlie functional renal impairment are incompletely understood in HFpEF. With a background of vascular conditions such as hypertension and diabetes, HFpEF patients are at risk of developing intra-renal vascular hemodynamic alterations that may lead to functional renal impairment. Accordingly, the present investigation aimed to evaluate the intra-renal circulation in HFpEF by noninvasive measurement of renal resistive index (RRI) by Doppler ultrasonic examination. To investigate the clinical relevance of intra-renal vascular hemodynamics, we assessed the prognostic value of RRI for all-cause mortality or hospitalization for HF decompensation. We tested the hypothesis that RRI is elevated in HFpEF patients compared to age-and sex-matched hypertensive patients who do not have evidence of HF and that elevated RRI predicts all-cause mortality or hospitalization for HF.
Materials and methods

Participants
Patients with HFpEF. We prospectively recruited 90 clinically stable patients among the 532 patients who, within the last 2 years, have been hospitalized at our institution for HF decompensation with an LV ejection fraction !50%. At time of enrollment, all patients met the Framingham criteria for HF (see Appendix for Supplementary table) and had physical and radiographic findings of pulmonary congestion [8] . Of the 532 patients with preserved LV ejection fraction who were hospitalized for HF decompensation, 442 were excluded from the study due to the presence of one or more of the following comorbidities: acute coronary syndrome, bradycardia related to atrioventricular or sinoatrial block, cardiac pacemaker, restrictive/hypertrophic cardiomyopathy or constrictive pericarditis, primary cardiac valvular disease or prosthetic valve, dialysis-dependent renal failure, renal artery stenosis or nephrotic syndrome, cor pulmonale or other causes of isolated right ventricular failure, congenital heart disease, hepatic cirrhosis or high output cardiac failure.
Controls. Ninety control patients were selected from 840 ambulatory patients who, without evidence or HF history, were receiving treatment for hypertension as outpatients. Control patients were matched for age (within 2 years), sex, hypertension and diabetic status with case patients. Case and control patients were simultaneously enrolled in the study.
Data collection
Data were collected on an outpatient basis once HFpEF patients no longer showed clinical evidence of fluid accumulation and had returned to their baseline asymptomatic state (on average 2-4 weeks after the episode of HF decompensation).
Body mass index was calculated as weight (kilograms)/height 2 (square meter). Clinical data included age, sex and past medical history including smoking, hypertension, hypercholesterolemia and diabetes mellitus. Clinical history including cardiac and non-cardiac history was based on physician and patient reporting and review of the medical record. Documented coronary artery disease (CAD) was defined as a history of previous myocardial infarction or the presence of significant CAD at angiography (>50% stenosis of an epicardial vessel). Blood samples were drawn for serum creatinine, urea, sodium, protein, C-reactive protein (CRP), fasting glucose, cholesterol and hemoglobin levels determinations. Glomerular filtration rate (eGFR) was estimated by means of the four-component Modification of Diet in Renal Disease equation incorporating age, race, sex and serum creatinine concentration: eGFR ¼ 186 3 (serum creatinine level in milligrams per deciliter) À1.154 3 (age in years) À0.203 . For women, the product of this equation was multiplied by a correction factor of 0.742 [9] . All study patients were Caucasian of French or North African origin.
Ultrasound Doppler of renal vasculature
Pulsed Doppler examinations of the intra-renal arterial circulation were performed by the same operator using a 3.5 MHz transducer (ATL HDI 5000; Philips, Andover, MA). Intra-renal Doppler signals were obtained from the arcuate arteries at the corticomedullary junction. The peak systolic velocity (Vmax) and the minimal diastolic velocity (Vmin) were determined. The RRI (peak systolic velocity À minimum diastolic velocity/peak systolic velocity) was calculated by using six measurements (three from each of the two kidneys). Measurements were made over 10 cycle lengths in patients with atrial fibrillation. The mean RRI of the right and left kidneys was used for subsequent analyses.
Ventricular and vascular function
Echo Doppler examinations were performed using a multiple frequency 2-4 MHz transducer (SONOS 5500; Philips). Standard two-dimensional images were obtained in the parasternal, apical four-and two-chamber views. Mitral inflow and annulus velocities were measured. LV volumes and EF were calculated using the Simpson's method. LV longitudinal systolic function was estimated by measuring the peak systolic velocity of the lateral mitral annulus (S#) in Tissue Doppler Imaging (TDI). Diastolic parameters were assessed by peak velocities of the E wave (early diastole), the A wave (late diastole), the deceleration time of E wave, the e# wave (early diastolic lateral mitral annulus velocity in TDI). The E/e# ratio was calculated. Pulmonary artery systolic pressure was estimated by measurement of maximal tricuspid regurgitation velocity and estimation of right atrial pressure on the basis of imaging of the inferior vena cava [10] . Systemic vascular resistance (SVR) was calculated as follows: mean blood pressure/cardiac output, cardiac output being the product of stroke volume and heart rate.
Follow-up
The vital status of patients was monitored by telephone calls to referring cardiologists, primary care physicians and by review of medical records.
The primary end point of the study was death and hospitalization for HF decompensation after the index hospitalization.
Statistics
Statistical analysis was performed using the SAS system (SAS v8; SAS Institute).
Data are presented as mean AE standard deviation or median [25th-75th percentiles] for continuous variables and as proportions for categorical variables. Mean values of continuous variables for HFpEF patients and controls were compared either with two-sided Student's t-test or with Mann-Whitney U-test for independent samples depending on the normality of the data, preliminarily tested with Shapiro-Wilk tests. Categorical variables were compared using the chi-square test.
A logistic regression analysis was performed to identify independent clinical, biological and Doppler ultrasonic data associated with HFpEF. For each continuous variable, we investigated the log-linearity assumption by introducing a quadratic component. In the case of non-log-linearity, the continuous variable was transformed into a binary variable, the cutoff value for dichotomization being the value minimizing the Akaike's information criterion. Then the variable, either continuous or transformed, was selected as a potential predictor of HFpEF whether its associated P-value in a univariate logistic regression model was <0.2. A forward stepwise multiple logistic regression was used to select independent predictors of HFpEF, the variables entering the model being considered significant with a Pvalue <0.05. Goodness of fit of the multivariate model was assessed by the significance of the Hosmer-Lemeshow test to measure the model's calibration and by the area under the Receiver Operating Characteristic (ROC) curve to measure its discrimination.
In the subsample of HFpEF, the Kaplan-Meier product limit method was used to estimate the survival rates at 1, 2 and 3 years and the median survival time. The reverse Kaplan-Meier method was used to estimate the median follow-up time.
Cox regression models were performed to assess the predictive value of the clinical, biological and Doppler ultrasonic parameters. For each variable, the proportional hazard assumption was checked by including a time-dependent covariable in the model. For continuous variables, the log-linearity assumption was checked as detailed for the logistic regression. For illustration purpose only, HFpEF patients were divided into two groups depending on mean RRI: mean RRI was dichotomized at the cutoff value minimizing the Akaike's information criterion and the Kaplan-Meier product limit method was used to plot survival curves in the so-defined groups.
A multiple Cox regression was finally performed to select independent predictors of survival, with a procedure similar to that used for the multiple logistic regression.
Results
Clinical and laboratory parameters in HFpEF patients and controls
The clinical characteristics of HFpEF and controls are summarized in Table 1 . Mean age was 75 AE 9 years in HFpEF patients. Ninety-two percent of HFpEF patients were hypertensive, 80% were women and 47% were diabetic. More HFpEF patients than controls were receiving beta-adrenergic blocking agents and diuretics, while as many HFpEF patients as controls were treated with angiotensin-converting enzyme inhibition and angiotensin II receptor blockade. Systolic, diastolic and mean blood pressures were lower in HFpEF patients than in controls (P ¼ 0.0002, P < 0.0001 and P < 0.0001, respectively). The laboratory findings in HFpEF patients and controls are detailed in Table 2 . eGFR, hemoglobin and serum protein levels were lower in HFpEF patients than in controls (P ¼ 0.016, P < 0.0001, and P ¼ 0.008, respectively), while serum CRP and urea plasma levels were greater (P < 0.0001 and P ¼ 0.0004, respectively).
RRI in HFpEF patients and controls
Mean RRI was greater in HFpEF patients than in controls (all P < 0.0001, Table 3 ) and was strongly associated with diagnosis of HFpEF [univariate odds ratio 1.32 (1.23-1.42), P < 0.0001, area under ROC curve 0.92).
Doppler-echocardiographic parameters in HFpEF patients and controls
Systolic pulmonary artery pressure, left atrial area, E/A and E/e# ratio were significantly greater in HFpEF patients than in controls ( Table 3 ). The early diastolic mitral annular velocity e# did not differ between the two groups of patients, while the systolic mitral annular velocity S# was lower in HFpEF patients than in controls (Table 3) . SVRs were significantly lower in HFpEF patients than in controls (Table 3) .
Independent prognostic indices by multivariate analysis
By multivariable analysis, mean RRI (P < 0.0001), mean blood pressure (P ¼ 0.007), left atrial area (P ¼ 0.0006) and E/e# (P ¼ 0.014) were independently associated with HFpEF (Hosmer-Lemeshow test: P ¼ 0.5103, Table 4 ). Adjustment for univariate clinical, biological and echocardiographic factors associated with HFpEF slightly improved the discriminant value of the model including RRI alone (area under ROC curve 0.97). 
Predictive value of RRI in HFpEF
Discussion
The underlying alterations that mediate the development and progression of HFpEF remain unclear [1] . The majority of HFpEF patients have a background of hypertension, impaired LV relaxation and increased LV stiffness and mass [11] . However, alterations other than impaired LV relaxation and increased LV stiffness and mass may play a role in HFpEF as patients with hypertension without any history or evidence of HF often exhibit similar LV diastolic alterations to those noted in HFpEF [11] . The present data indicate that HFpEF patients have intra-renal vascular hemodynamic alterations compared with age-and gendermatched hypertensive patients who have no history or evidence of HF. Moreover, the severity of intra-renal vascular hemodynamic alterations predicts a poor outcome in HFpEF. The role of intra-renal hemodynamic alterations in the progression of HFpEF and possibly as a therapeutic target needs further consideration.
Renal ultrasound Doppler waveform analysis of the intra-renal arterial circulation allows measurement of RRI and thereby provides a reliable noninvasive evaluation of intra-renal vascular hemodynamics. As recently discussed by Raff et al. [12] , renal vascular resistance is not the primary determinant of RRI but is a complex integral of different factors such as vascular resistance vessels compliance of large arteries and pulse pressure. Intra-renal vascular hemodynamic alterations are known to precede functional renal impairment as quantified by eGFR [13, 14] . The underlying mechanisms of intra-renal hemodynamic alterations remain to be elucidated in HFpEF. Heightened sympathetic activity affects both systemic and intra-renal circulation in HF [15] . However, SVRs were unexpectedly lower in HFpEF patients than in hypertensive controls. Anemia, a frequent comorbid condition of HFpEF probably contributed to lower SVRs in HFpEF patients [16, 17] who exhibited an inverse correlation between hemoglobin concentration and SVRs (r ¼ 0.29, P ¼ 0.013). Disparate responses of the systemic and intrarenal vascular circulation have been previously reported by Elkayam et al. [18] . Age, heart rate and hypertension may affect RRI [15] [16] [17] [18] [19] . Age and heart rate was similar in HFpEF patients and controls. Systolic and diastolic blood pressure were lower in HFpEF patients than in controls but RRI remained significantly different in HFpEF patients and controls after adjusting for blood pressure, kidney function and antihypertensive agents including diuretic therapy. Diuretic therapy may affect the intra-renal arterial circulation by promoting vasoconstriction due to heightened sympathetic stimulation. At the time of Doppler ultrasonic renal examination, none of the patients exhibited overt clinical evidence of intra-vascular volume depletion. Serum sodium concentration was similar in HFpEF patients and controls (Table 2) . Of note, diuretic therapy may lower RRI by reducing renal venous pressure as demonstrated in an experimental porcine model [20] . The exact mechanisms that mediate heightened intrarenal vascular hemodynamic alterations in HFpEF cannot be ascertained from the present data. Heightened sympathetic tone resulting from enhanced skeletal muscle mechanoreceptor activity increases intra-renal vascular resistances in HF patients with reduced ejection fraction [21] . Whether skeletal muscle mechanoreceptor activity is increased in HFpEF patients has not yet been investigated to our knowledge. Hypertension and diabetes may promote functional intra-renal vascular hemodynamic alterations that underlie the development of renal functional impairment and the symptomatic progression of HFpEF. Such a paradigm is supported by the observation that elevated RRI is a strong and independent predictor of cardiovascular target organ damage including LV hypertrophy and diastolic dysfunction as well as of kidney dysfunction in a large population of hypertensive patients [22] .
The HFpEF patients enrolled in the present study exhibited typical echocardiographic Doppler findings of HFpEF including elevated E/e# ratio and increased left atrial size [23] . LV hypertrophy tended to be more severe in HFpEF patients than in control patients. LV systolic function was impaired in HFpEF patients compared to control patients as previously reported [24] . Latent LV systolic dysfunction may be partly responsible for the lower mean arterial blood pressure of HFpEF patients when compared to control patients with hypertension and no evidence of HF.
The parameters that predicted outcome in the present cohort of patients are similar to those reported in larger HFpEF registries. Low hemoglobin concentration is highly prevalent and is used for predicting outcome in HFpEF [5] . Similarly, the impact of renal insufficiency on morbidity and mortality is well recognized in HFpEF [6, 25] . Of note, after adjustment for all known prognostic indicators in HFpEF, RRI emerged as an independent predictor of poor outcome in our cohort of HFpEF patients.
Discussions
Invasive measurements were not performed in the present study. The cross-sectional and nonlongitudinal nature of the study somewhat weakens our observation that RRI is elevated in HFpEF. Elevated RRI may result from HF rather than play a role in its pathogenesis. Although the use of arm cuff blood pressure may not reflect accurately the aortic blood pressure, the differences observed between HFpEF and control patients are unlikely to be an artefact as central blood pressure becomes similar to peripheral blood pressure as the central-to-peripheral stiffness gradient attenuates with advancing age [26] . Lastly, the present study may be biased as control hypertensive patients were recruited from an outpatient facility and not from the community.
Conclusions
Patients with HFpEF have elevated RRI compared to age-, sex-and comorbidities-matched control patients with hypertension who do not have HF. Elevated RRI predicts a poor outcome in HFpEF. Akin to impaired LV relaxation and increased LV mass, intra-renal vascular hemodynamic alterations may be a component of the HFpEF syndrome.
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